A higher CD4+ could be expected to be an earlier event in the sequence of immune process, whereas a preponderance of CD68+ could be a late event reflecting the culmination of the immune process and scavenging the dead tumor cells by CD68+ macrophages. This evidence concerns the gene CD4 and neoplasm.